The estimated frequency of antiphospholipid antibodies in young adults with cerebrovascular events: a systematic review

scientific article

The estimated frequency of antiphospholipid antibodies in young adults with cerebrovascular events: a systematic review is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1136/ANNRHEUMDIS-2014-205663
P698PubMed publication ID24942381
P5875ResearchGate publication ID264635050

P50authorLaura AndreoliQ61806166
Munther A. KhamashtaQ73418907
Maria Josè CuadradoQ89547142
Savino SciasciaQ89547145
P2093author name stringDoruk Erkan
Maria Laura Bertolaccini
Giovanni Sanna
APS Action
P2860cites workInternational consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)Q28292418
Cerebral infarction associated with lupus anticoagulants--preliminary reportQ33478161
International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshopQ33685960
Diagnostic testing for coagulopathies in patients with ischemic strokeQ34099965
Risk factors for ischemic stroke and transient ischemic attack in patients under age 50Q34472618
Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literatureQ34977289
Anti-beta 2-glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndromeQ35158386
Canadian pregnancy outcomes in rheumatoid arthritis and systemic lupus erythematosusQ35417804
Ischaemic stroke in young adults: predictors of outcome and recurrenceQ35485985
Young strokes in Sri Lanka: an unsolved problemQ36570388
Estimated frequency of antiphospholipid antibodies in patients with pregnancy morbidity, stroke, myocardial infarction, and deep vein thrombosis: a critical review of the literatureQ38122121
Clinical course of high-risk patients diagnosed with antiphospholipid syndromeQ39934417
Use of methodological standards in diagnostic test research. Getting better but still not good.Q40461184
beta(2)-Glycoprotein 1-dependent anticardiolipin antibodies and risk of ischemic stroke and myocardial infarction: the honolulu heart programQ40693493
Factors that predict antiphospholipid immunoreactivity in young people with transient focal neurological eventsQ40835330
Risk factors for thrombophilia in young adults presenting with thrombosisQ43235975
Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study: a case-control study.Q43626449
Do antiphospholipid antibodies increase the long-term risk of thrombotic complications in young patients with a recent TIA or ischemic stroke?Q43717978
Antiphospholipid antibodies in the acute phase of cerebral ischaemia in young adults: a descriptive study of 139 patientsQ43933330
Antiphospholipid antibodies and stroke in young womenQ44168396
Antiphospholipid antibodies in young Indian patients with strokeQ44395700
Thrombophilic screening in young patients (< 40 years) with idiopathic ischemic stroke: a controlled studyQ46061041
Causes of ischemic stroke in young adults in Thailand: a pilot study.Q46548942
Antiphospholipid antibodies and cerebral artery dissection: two frequent causes of brain ischemia in young adultsQ48114647
High prevalence of antiphosphatidylinositol antibodies in young patients with cerebral ischemia of undetermined causeQ48398617
Anticardiolipin antibodies, a disease marker for ischemic cerebrovascular events in a younger patient population?Q48437611
Lupus anticoagulant and anticardiolipin antibodies in young adults with cerebral ischemiaQ48537242
Anticardiolipin antibodies in ischemic stroke in the young: Indian experienceQ48630330
Incidence of a first thromboembolic event in asymptomatic carriers of high-risk antiphospholipid antibody profile: a multicenter prospective study.Q50619255
Patent foramen ovale and prothrombotic markers in young stroke patients.Q51739841
Ischemic stroke in young adults. Experience in 329 patients enrolled in the Iowa Registry of stroke in young adults.Q52342334
Clinical utility of anticardiolipin antibody assays: high inter-laboratory variation and limited consensus by participants of external quality assurance programs signals a cautious approach.Q52913630
Prothrombotic factors and the risk of acute onset non-cardioembolic stroke in young Asian Indians.Q54475683
Antiphospholipid syndromeQ55891386
Lupus anticoagulant and the fibrinolytic system in young patients with strokeQ58421453
P433issue11
P407language of work or nameEnglishQ1860
P921main subjectsystematic reviewQ1504425
P304page(s)2028-2033
P577publication date2014-06-18
P1433published inAnnals of the Rheumatic DiseasesQ4767876
P1476titleThe estimated frequency of antiphospholipid antibodies in young adults with cerebrovascular events: a systematic review
P478volume74

Reverse relations

cites work (P2860)
Q90446471A challenging case of neuropsychiatric systematic lupus erythematosus with recurrent antiphospholipid- related stroke: A case report and literature review
Q48020789Anti-mullerian hormone levels decline with the presence of antiphospholipid antibodies
Q27007774AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION): 5-Year Update
Q34171339Antigen-specific immune reactions to ischemic stroke.
Q57490088Antiphospholipid Antibodies to Domain I of Beta-2-Glycoprotein I Show Different Subclass Predominance in Comparison to Antibodies to Whole Beta-2-glycoprotein I
Q59808719Antiphospholipid Syndrome and the Neurologist: From Pathogenesis to Therapy
Q64046338Antiphospholipid syndrome
Q91390119Antiphospholipid syndrome - an update
Q38410376Antiphospholipid syndrome: an update
Q90415557Cerebrovascular Events in Systemic Lupus Erythematosus: Diagnosis and Management
Q47998109Diagnosing antiphospholipid syndrome: 'extra-criteria' manifestations and technical advances
Q90706672IgG Anti-high-Density Lipoproteins Antibodies Discriminate Between Arterial and Venous Events in Thrombotic Antiphospholipid Syndrome Patients
Q50041259Immunological Rare Diseases
Q64043321Infodemiology of antiphospholipid syndrome: Merging informatics and epidemiology
Q90521167MicroRNA (miRNA): A New Dimension in the Pathogenesis of Antiphospholipid Syndrome (APS)
Q51251394Neuropsychiatric Lupus in clinical practice.
Q60920514Posterior Reversible Encephalopathy Syndrome with Stroke in Puerperal Woman with High Titer of Anti-Phospholipid IgM Antibody
Q54266701Prothrombotic factors do not increase the risk of recurrent ischemic events after cryptogenic stroke at young age: the FUTURE study.
Q64088190Recurrent Stroke Due to Antiphospholipid Syndrome Remitted by Immunotherapy, Not by Anticoagulation Therapy: A Case Report and Literature Review
Q47311457Spontaneous cervical artery dissection is accompanied by a hypercoagulable state and simultaneous inflammatory condition
Q38844621Stroke in systemic lupus erythematosus and antiphospholipid syndrome: risk factors, clinical manifestations, neuroimaging, and treatment
Q42646992Subsequent Thrombotic Outcomes in Patients with Ischemic Stroke with Antiphospholipid Antibody Positivity
Q48509173The cutaneous manifestations are significantly related to cerebrovascular in a Serbian cohort of patients with Hughes syndrome
Q38374306The journey of antiphospholipid antibodies from cellular activation to antiphospholipid syndrome
Q45873735The risk of ischaemic stroke in primary antiphospholipid syndrome patients: a prospective study
Q88930539Thrombosis and Anti-phospholipid Syndrome: a 5-Year Update on Treatment
Q26739950Thrombotic risk assessment in antiphospholipid syndrome: the role of new antibody specificities and thrombin generation assay

Search more.